0000950170-24-001827.txt : 20240104
0000950170-24-001827.hdr.sgml : 20240104
20240104160053
ACCESSION NUMBER: 0000950170-24-001827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morich Frank
CENTRAL INDEX KEY: 0001748615
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 24511699
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
ownership.xml
4
X0508
4
2024-01-02
false
0001645460
Cue Biopharma, Inc.
CUE
0001748615
Morich Frank
C/O CUE BIOPHARMA, INC.
40 GUEST STREET
BOSTON
MA
02135
true
false
false
false
false
Stock Option (right to buy)
2.78
2024-01-02
4
A
false
24400
0.0
A
2034-01-01
Common Stock
24400
24400
D
Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date.
/s/ Frank Morich by Colin Sandercock, attorney-in-fact
2024-01-04